Skip to content
Trial Eligibility
Menu

Treating Insomnia in Mild Cognitive Impairment

NCT06687161

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The goal of this study is to test a new way to improve sleep quality in persons living with mild cognitive impairment. The treatment combines a safe and gentle way to stimulate the brain, called transcranial magnetic stimulation, with a psychological treatment, called cognitive behavioral therapy for insomnia.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Mild Cognitive Impairment (MCI)
  • Insomnia

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
60 years and older
Sex
All
Healthy volunteers
Not accepted
Sponsor
Beth Israel Deaconess Medical Center
Last updated on ClinicalTrials.gov
October 24, 2025

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Massachusetts · 1

  • Beth Israel Deaconess Medical Center · Boston, MA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.